These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. Yang XX, Hu ZP, Xu AL, Duan W, Zhu YZ, Huang M, Sheu FS, Zhang Q, Bian JS, Chan E, Li X, Wang JC, Zhou SF. J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871 [Abstract] [Full Text] [Related]
3. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort. Hu ZP, Yang XX, Chen X, Cao J, Chan E, Duan W, Huang M, Yu XQ, Wen JY, Zhou SF. Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494 [Abstract] [Full Text] [Related]
4. Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation. Allegrini G, Di Paolo A, Cerri E, Cupini S, Amatori F, Masi G, Danesi R, Marcucci L, Bocci G, Del Tacca M, Falcone A. Cancer Chemother Pharmacol; 2006 Nov; 58(5):585-93. PubMed ID: 16680463 [Abstract] [Full Text] [Related]
10. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat. Yang X, Hu Z, Chan SY, Goh BC, Duan W, Chan E, Zhou S. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul 25; 821(2):221-8. PubMed ID: 15936253 [Abstract] [Full Text] [Related]
12. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen. Kurita A, Kado S, Matsumoto T, Asakawa N, Kaneda N, Kato I, Uchida K, Onoue M, Yokokura T. Cancer Chemother Pharmacol; 2011 Jan 25; 67(1):201-13. PubMed ID: 20354702 [Abstract] [Full Text] [Related]
13. Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of irinotecan hydrochloride in rats. Yokooji T, Kawabe Y, Mori N, Murakami T. J Pharm Pharmacol; 2013 Feb 25; 65(2):280-91. PubMed ID: 23278696 [Abstract] [Full Text] [Related]
16. Influence of multiple dose activated charcoal on the disposition kinetics of irinotecan in rats. Balram C, Zhou QY, Cheung YB, Lee EJ. Drug Metabol Drug Interact; 2002 Feb 25; 19(2):137-48. PubMed ID: 12751911 [Abstract] [Full Text] [Related]
17. Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats. Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, Yokoi T, Kamataki T. Cancer Chemother Pharmacol; 1998 Feb 25; 42(4):280-6. PubMed ID: 9744772 [Abstract] [Full Text] [Related]